Pertussis: Challenges Today and for the Future

article has not abstract

Vyšlo v časopise: Pertussis: Challenges Today and for the Future. PLoS Pathog 9(7): e32767. doi:10.1371/journal.ppat.1003418
Kategorie: Pearls
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1003418

Souhrn

article has not abstract

Zdroje

1. Cherry JD, Heininger U (2009) Pertussis and other Bordetella infections. In: Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan S, editors. Feigin and Cherry's textbook of pediatric infectious diseases. 6th edition. Philadelphia, PA: WB Saunders Co. pp. 1683–1706.

2. Holmes WH (1940) Whooping-cough, or pertussis. In: Holmes WH, editor. Bacillary and rickesttsial infections acute and chronic - a textbook. New York: The MacMillan Company. pp. 395–414.

3. Lapin JH (1943) Whooping cough. Springfield, IL: Charles C. Thomas Publishing. 112–122 p.

4. MattooS, CherryJD (2005) Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 18: 326–382.

5. Cherry JD, Paddock CDJ (2013) What Bordetella pertussis toxins and other proteins do and do not do in the pathogenesis of pertussis. Presented at: Pediatric Academic Scoieties Annual Meeting; May 2013; Washington, DC.

6. MurrayEL (2013) Characteristics of severe Bordetella pertussis infection among infants ≤90 days of age admitted to pediatric intensive care units- Southern California, September 2009–June 2011. J Pediatric Infect Dis Soc 1–6.

7. PaddockCD, SandenGN, CherryJD, GalAA, LangstonC, et al. (2008) Pathology and pathogenesis of fatal Bordetella pertussis infection in infants. Clin Infect Dis 47: 328–338.

8. CherryJD (2003) The science and fiction of the “resurgence” of pertussis. Pediatrics 112: 405–406.

9. CherryJD (2005) The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics 115: 1422–1427.

10. CherryJD (2010) The present and future control of pertussis. Clin Infect Dis 51: 663–667.

11. CherryJD (2012) Epidemic pertussis in 2012–the resurgence of a vaccine-preventable disease. N Engl J Med 367: 785–787.

12. CherryJD (2012) Why do pertussis vaccines fail? Pediatrics 129: 968–970.

13. CherryJD, OlinP (1999) The science and fiction of pertussis vaccines. Pediatrics 104: 1381–1383.

14. World Health Organization (1991) WHO meeting on case definition of pertussis: report of the meeting.Geneva, 10–11, Jan 1991. MIM/EPI/PERT/91.1

15. CherryJD, HeiningerU, StehrK, ChristensonP (1998) The effect of investigator compliance (observer bias) on calculated efficacy in a pertussis vaccine trial. Pediatrics 102: 909–912.

16. CherryJD, GornbeinJ, HeiningerU, StehrK (1998) A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 16: 1901–1906.

17. StorsaeterJ, HallanderHO, GustafssonL, OlinP (1998) Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 16: 1907–1916.

18. CherryJD, HeiningerU, RichardsDM, StorsaeterJ, GustafssonL, et al. (2010) Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis. Clin Vaccine Immunol 17: 741–747.

19. PrestonNW (1965) Effectiveness of pertussis vaccines. Br Med J 2: 11–13.

20. SchmidtkeAJ, BoneyKO, MartinSW, SkoffTH, TondellaML, et al. (2012) Population diversity among Bordetella pertussis isolates, United States, 1935–2009. Emerg Infect Dis 18: 1248–1255.

21. MooiFR, van LooIH, van GentM, HeQ, BartMJ, et al. (2009) Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis 15: 1206–1213.

22. QueenanAM, CassidayPK, EvangelistaA (2013) Pertactin-negative variants of Bordetella pertussis in the United States. N Engl J Med 368: 583–584.

23. WeissAA, PattonAK, MillenSH, ChangSJ, WardJI, et al. (2004) Acellular pertussis vaccines and complement killing of Bordetella pertussis. Infect Immun 72: 7346–7351.

24. Olin P, Gustafsson L, Rasmussen F, Hallander HO, Hejibel H, et al. (1997) Efficacy trial of acellular pertussis vaccines; trial II. 1 Jan 1997. Swedish Institute for Infectious Disease Control. pp. 52–54.

25. LikoJ, RobisonSG, CieslakPR (2013) Priming with whole-cell versus acellular pertussis vaccine. N Engl J Med 368: 581–582.

26. SheridanSL, WareRS, GrimwoodK, LambertSB (2012) Number and order of whole cell pertussis vaccines in infancy and disease protection. JAMA 308: 454–456.

27. MalloryFB, HornorAA (1912) Pertussis: The histological lesion in the respiratory tract. J Med Res 27: 115–124.